Nutritional and Toxic Disorders Flashcards
Opiate withdrawal
Occurs within hours to several days of cessation.
Dysphoria, myalgias, nausea, vomiting, rhinorrhea, lacrimation, piloerection, diaphoresis, diarrhea, mydriasis, fever and insomnia.
To differentiate from ETOH/Benzo withdrawal: Increased DTR are typical in ETOH/benzo withdrawal but not opiate.
Opioid receptor subtypes and their effects
Delta: analgesia, antidepressant effects, physical dependence
Kappa: spinal analgesia, sedation, miosis, inhibition of ADH release
Mu1: supraspinal analgesia and physical dependence
Mu2: respiratory depression, miosis, euphoria, reduced GI motility and physical dependence
ORL1/orphanin: anxiety, depression, appetite, tolerance
Amphetamine mechanism of action
direct release of dopamine and NE and inhibits their reuptake
Cocaine mechanism of action
primary: inhibits presynaptic reuptake of dopamine (as well as serotonin and NE)
Amphetamine and Cocaine Withdrawal
dysphoria, vivid/unpleasant dreams, increased appetite, insomnia or hypersomnia, agitation, psychomotor retardation
Stages of ETOH withdrawal
6-36 h: minor withdrawal symptoms–HA, tremors, diaphoresis, palpitations, insomnia, GI upset, diarrhea, anorexia, agitation, anxiety.
6-48 h: Seizures
12-48 h: ETOH hallucinosis
48-96h: Delirium tremens=delirium, hallucinations, disorientation, agitation, encephalopathy, hypertension, tachycardia, arrhythmias, low grade fever and diaphoresis
PCP mechanism of action
noncompetitive antagonist at glutamate NMDA receptor
also affects dopamine, NE, serotonin release and reuptake
Hallucinogen (LSD, psilocybin, mescaline) symptoms and mechanism of action
Symp: sensory distortions synesthesias, hallucinations, euphoria, anxiety, tachycardia, palpitations, mydriasis, diaphoresis
Primarily work at serotonin receptors (esp. 5HT2
Mercury toxicity
Exposure: fish and shellfish (organic form), inorganic forms in mining, dentistry, chloralkali industries, thermometer factories
If inhaled, a severe interstitial pneumonitis
Intention tremor, cerebellar ataxia, paresthesias, tender and inflamed gums, excessive salivation, swollen salivary glands, personality changes, psychiatric symptoms (anxiety, irritability, fearfulness, memory loss, depression, fatigue)
chemotherapy causing peripheral neuropathy
vincristine (sensory and motor), cisplatin, etoposide, taxol (painful dysesthesias)
chemotherapy causing leukoencephalopathy
methotrexate
chemotherapy causing aseptic meningitis
IT methotrexate
chemotherapy causing subacute pancerebellar syndrome
IV cytarabine, 5-fluorouracil
chemotherapy causing ICH or ischemic stroke
bevacizumab
chemotherapy causing SIADH
cyclophosphamide